Marksans Pharma Ltd

marksanspharma.com BSE: 524404 NSE : MARKSANS
About

Marksans Pharma is engaged in Business of Formulation of pharmaceutical products.

Website BSE NSE
  • Market Cap ₹ 2,155 Cr.
  • Current Price ₹ 52.6
  • High / Low ₹ 57.1 / 9.85
  • Stock P/E 39.7
  • Book Value ₹ 12.4
  • Dividend Yield 0.19 %
  • ROCE 11.4 %
  • ROE 7.76 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is virtually debt free.

Cons

  • Stock is trading at 4.26 times its book value
  • Company has a low return on equity of 6.90% for last 3 years.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
75 80 87 93 115 125 91 92 101 117 114 156
69 69 76 76 97 108 88 82 88 97 95 127
Operating Profit 6 12 11 17 18 17 3 10 13 20 18 29
OPM % 8% 14% 12% 18% 16% 14% 4% 11% 13% 17% 16% 19%
Other Income 0 0 0 3 3 0 10 2 8 0 -0 0
Interest 2 1 3 2 2 1 2 2 2 1 2 1
Depreciation 3 3 3 2 2 2 2 3 3 3 3 3
Profit before tax 1 8 6 17 17 14 9 8 16 16 13 25
Tax % -138% 27% 24% 17% 25% 16% 36% 28% 24% 19% 44% 11%
Net Profit 1 6 4 14 12 12 6 6 12 13 7 22
EPS in Rs 0.03 0.14 0.11 0.34 0.30 0.29 0.14 0.14 0.29 0.32 0.18 0.54
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
200 200 155 155 192 315 406 358 216 295 424 433 487
179 176 235 272 148 231 290 254 191 266 361 362 407
Operating Profit 20 24 -81 -118 44 84 116 104 24 29 63 71 80
OPM % 10% 12% -52% -76% 23% 27% 29% 29% 11% 10% 15% 16% 17%
Other Income 7 1 -79 2 4 3 3 9 7 7 8 0 8
Interest 15 15 39 49 10 15 13 6 4 8 7 7 6
Depreciation 10 10 15 18 9 9 9 15 15 12 9 12 12
Profit before tax 2 1 -213 -183 30 63 97 92 12 17 56 53 70
Tax % 79% 54% -2% 1% -34% 12% 31% 22% 3% 25% 22% 28%
Net Profit 0 0 -218 -181 40 56 67 71 12 12 44 38 54
EPS in Rs 1.03 1.42 1.61 1.72 0.19 0.30 1.07 0.93 1.33
Dividend Payout % 0% 0% 0% 0% 0% 7% 7% 7% 18% 16% 5% 11%
Compounded Sales Growth
10 Years:8%
5 Years:1%
3 Years:26%
TTM:15%
Compounded Profit Growth
10 Years:60%
5 Years:-11%
3 Years:49%
TTM:53%
Stock Price CAGR
10 Years:30%
5 Years:-12%
3 Years:7%
1 Year:277%
Return on Equity
10 Years:%
5 Years:8%
3 Years:7%
Last Year:8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
50 50 50 50 52 52 53 53 41 41 41 41
Reserves 109 125 -92 -240 58 108 305 369 378 388 430 465
Borrowings 319 353 103 100 91 89 50 41 73 67 78 0
62 60 359 345 123 141 132 83 54 61 64 88
Total Liabilities 526 575 407 243 310 376 527 534 546 557 612 594
279 294 185 77 73 67 90 97 94 88 103 115
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 68 78 68 24 68 68 68 231 234 236 236 236
180 204 154 142 170 242 369 205 217 233 273 243
Total Assets 526 575 407 243 310 376 527 534 546 557 612 594

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
89 12 -68 -61 9 54 112 65 -14 16 20 118
-142 -34 26 41 -48 -2 -29 -177 -8 -8 -20 -24
22 42 36 11 22 -19 51 -52 21 -10 1 -92
Net Cash Flow -30 20 -6 -9 -17 33 134 -164 -1 -2 1 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 4% 3% -32% 71% 35% 33% 22% 3% 5% 12% 11%
Debtor Days 93 123 170 175 174 130 112 136 262 209 153 136
Inventory Turnover 1.25 1.67 1.81 2.28 2.34 3.29 4.24 3.92 3.27 4.93 4.34 3.47

Shareholding Pattern

Numbers in percentages

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25
4.73 3.16 4.30 4.09 3.59 3.45 3.18 2.46 2.44 2.54 3.28 4.69
0.40 1.74 0.34 0.47 0.50 0.62 0.51 0.66 0.64 0.89 0.67 0.30
46.62 46.85 47.11 47.19 47.66 47.68 48.06 48.64 48.67 48.32 47.80 46.76

Documents

Recent announcements


View all

Annual reports

Credit ratings